Quick Summary:
In an ever-evolving medical devices industry, staying ahead of the competition is key. One way to do this is by leveraging comprehensive, insight-filled reports such as 'Bioabsorbable Stents (BAS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update.' This report provides an in-depth analysis of the BAS products under development, key players in the sector, and ongoing clinical trials, giving you a well-rounded understanding of the current landscape.
This sector report reveals a more profound level of understanding, offering not only product descriptions but also licensing, collaboration details and other significant developmental activities. It explores the different stages of development of BAS, from Early Development to Approved/Issued stage, allowing you to strategize effectively for market entry and expansion. By unveiling valuable competitor information, the report empowers you to formulate impactful strategies and establish a competitive advantage. From planning mergers to acquisitions, the insights gained from the report will enable you to navigate the Bioabsorbable Stents (BAS) market with ease. Traverse this sector with confidence; embrace the opportunity to lead.
Speak directly to the analyst to clarify any post sales queries you may have.
Bioabsorbable stents are also known as bioreabsorbable or biodegradable coronary stents. The advantage of this stent is that it does not leave any metal body behind and hence, the possibility of late-stent thrombosis and restenosis decreases. Bioabsorbable stents help in better drug delivery compared to metallic stents.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Bioabsorbable Stents (BAS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Bioabsorbable Stents (BAS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Bioabsorbable Stents (BAS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Vascular Inc
- Amaranth Medical Inc
- Arterius Ltd
- Biosensors International Group Ltd
- Biosten, LLC
- Biotronik AG
- Biotronik SE & Co KG
- Biotyx Medical (Shenzhen) Co Ltd
- Boston Scientific Corp
- Cardionovum GmbH
- Cordis Corp
- HangZhou HuaAn Biotechnology Co., Ltd.
- Icon Interventional Systems, Inc.
- Japan Stent Technology Co., Ltd.
- Kyoto Medical Planning Co Ltd
- Lifetech Scientific (Shenzhen) Co Ltd
- Manli Cardiology Ltd
- Meril Life Sciences Pvt Ltd
- Micell Technologies Inc
- Michigan Technological University
- MicroPort Scientific Corp
- Minvasys SAS
- MIV Therapeutics Inc
- NanoCoeur, Inc.
- North Carolina State University
- Northwestern University
- OrbusNeich
- Pediastent LLC
- QualiMed Innovative Medizinprodukte GmbH
- REVA Medical Inc
- S3V Vascular Technologies
- Shanghai Bio-heart Biological Technology Co Ltd
- Shanghai Healing Medical Instruments Co Ltd
- Tepha Inc
- Tremedics Medical Devices LLC
- UAB Minority Health and Health Equity Research Center
- University of Florida
- University of Strathclyde
- VasoTech Inc.
- Xenogenics Corporation
